| CD93: Recent Advances and Implications in Disease. | |
| | |
MedLine Citation:
|
PMID: 22206251 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
While it has been known for some time that CD93 regulates several processes involved in innate immunity and inflammation including phagocytosis and adhesion, the function of CD93 in disease progression is only now being elucidated. Recent in vivo studies in mice, and genome wide studies in mice and humans, have provided clues about its molecular function. Following a comprehensive review of CD93 expression patterns, this review will focus on recent findings over the last three years that address the putative function of CD93 in inflammation and innate immunity. |
| | |
Authors:
|
Mallary C Greenlee-Wacker; Mallary Galvan; Suzanne S Bohlson |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-12-29 |
Journal Detail:
|
Title: Current drug targets Volume: - ISSN: 1873-5592 ISO Abbreviation: - Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2011-12-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960531 Medline TA: Curr Drug Targets Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556, USA. Suzanne.S.Bohlson.2@nd.ed. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thrombomodulin Links Coagulation to Inflammation and Immunity.
Next Document: The role of streptokinase as a virulence determinant of Streptococcus pyogenes - potential for thera...